Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: Natl India
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Merck Ltd/India

+ Add to Watchlist

EMER:IN

838.15 INR 38.30 4.37%

As of 07:08:13 ET on 04/24/2015.

Snapshot for Merck Ltd/India (EMER)

Open: 878.00 Day's Range: 831.00 - 878.00 Volume: 36,507
Previous Close: 876.45 52wk Range: 611.05 - 1,009.00 1-Yr Rtn: +25.85%

Stock Chart for EMER

No chart data available.
  • EMER:IN 838.15
  • 1D
  • 1M
  • 1Y
876.45
Interactive EMER Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for EMER

Current P/E Ratio (ttm) 32.1906
Estimated P/E(-) -
Relative P/E vs. SENSEX 1.6894
Earnings Per Share (ttm) 26.0371
Est. EPS -
Est. PEG Ratio -
Market Cap (M INR) 13,912.77
Shares Outstanding (M) 16.60
30 Day Average Volume 46,945
Price/Book (mrq) 2.5100
Price/Sale (ttm) 1.6713
Dividend Indicated Gross Yield 0.72%
Cash Dividend (INR) 6.0000
Dividend Ex-Date 03/30/2015
5 Year Dividend Growth -21.40%
Next Earnings Announcement 05/07/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for EMER

  • Revenue
  • Net Income (M/INR)
  • Profit Margin (%)

Company Profile & Key Executives for EMER

Merck Ltd. manufactures pharmaceutical drugs, reagents, bulk drugs, diagnostic equipment, pigments, chemicals, and pesticides. The Company's major products include neurotropic specialties such as encephabol, anti-psychotics such as l ithocarb and vitamin formulations such as neurobion, polybion, multiboonata, e tc.

Anand NambiarManaging DirectorAli SleimanExec Dir:Serono Division
N KrishnanCFO/Exec Dir:FinanceBrijesh KapilExec Dir:Consumer Health
More Company Profile & Key Executives for EMER

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil